Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 1000+ Conferences, 1000+ Symposiums and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series LLC Ltd : World’s leading Event Organizer

Conference Series LLC Ltd Conferences gaining more Readers and Visitors

Conference Series LLC Ltd Web Metrics at a Glance

  • 3000+ Global Events
  • 100 Million+ Visitors
  • 75000+ Unique visitors per conference
  • 100000+ Page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Renowned Speakers

Frederic Checler

Frederic Checler

University of Nice-Sophia-Antipolis France

Dr. Gianna C. Riccitelli

Dr. Gianna C. Riccitelli

University of Italian Switzerland

 Daifulah ALZahrani

Daifulah ALZahrani

King Saud Bin Abdulaziz University for Health Sciences, United Arab Emirates

Tian Yuyao

Tian Yuyao

University of HongKong, Hong Kong

Kiss T.Freeman

Kiss T.Freeman

University of Liberia, Finland

Hend M. El Tayebi

Hend M. El Tayebi

German University, Egypt

Recommended Global Nursing Webinars & Conferences

Europe & UK
Asia Pacific & Middle East
Canada

Dementia & Alzheimer disease

About us

Conference Series welcomes every one of the members across the world to go to International Conference on Dementia and Alzheimer sickness to be held during November 21-22, 2022 in Rome, Italy  time region which incorporates brief feature introductions, Oral talks, e-Poster introductions, Young Research Forum(YRF) and Exhibitions.
 
Why to Attend?
 
The Dementia 2021 speaks with people across the globe focused in on getting some answers concerning cautious and its qualities. This is the most perfect opportunity to show up at the greatest individuals. Sharing the data and displays, information and B2B social events with industrialists and anticipated that customers should make a sprinkle with innovative things live and brand affirmation at this event. Extraordinarily celebrated speakers, the most recent methodologies, and the latest degrees of progress in Dementia are indications of this gathering
 
Target Audience:
 
  • Neurologists and Directors
  • Physicians
  • Neuroscientists
  • Specialists
  • researchers
  • Health care professionals
  • Professors
  • Industrial Experts
  • Neurosurgeons
  • Psychiatrist
  • Nutritional Scientists
  • Lecturers and Students from Academia in the study of Dementia
 

 

 

Scientific Sessions

Scientific Session 1:  Dementia
 
Dementia may be a constant or diligent issue of the psychological volume unit caused by cerebrum sicknesses or wounds set apart due to character changes, memory problems and disabled thinking. Dementia is anything but a particular infection. It's a gathering of manifestations related with a decrease in memory or other reasoning capacity abilities enough to diminish an individual's capacity exercises. Different sorts of dementia are related with specific sorts of synapse harm specifically districts of the cerebrum
 
 
Scientific Session 2Vascular Dementia
Vascular dementia, which happens following a stroke, is the second most regular dementia type. However, there are numerous different conditions which will cause manifestations of dementia, including some that are reversible, like thyroid issues and nutrient inadequacies. In vascular dementia, changes in reasoning abilities now and again happen unexpectedly following strokes that square significant mind veins. Thinking issues likewise may start as gentle changes that deteriorate progressively due to various minor strokes or different conditions that influence smaller veins, prompting total harm
 
 
Scientific Session 3Alzheimers Disease
Alzheimer's disease is irreversible and decimates cerebrum cells, making thinking capacity and memory weaken. Alzheimer's infection is a dynamic, degenerative mind ailment and the most widely recognized type of dementia, a gathering of brain disorders that influence a man's memory, considering and capacity to connect socially. Dementia and Alzheimer's infection isn’t the same. Dementia is a general term used to depict indications that effect memory, execution of day by day exercises, and correspondence capacities. Alzheimer's infection is the most widely recognized kind of dementia.
 
 
Scientific Session 4Dementia stages
Dementia in "stages," alludes how far a person's dementia has been advanced. It characterizes a person's infection stage assisting doctors with deciding the simplest treatment approach and help correspondence between wellbeing suppliers and parental figures. Here and there the stage is actually alluded to as "beginning phase", "center stage" or "late-stage" dementia, however regularly a more accurate stage is allocated, in light of a person's indications.
 
 
Scientific Session 5Dementia with Lewy Body (DLB)
Individuals with Lewy body dementia have a reformist decrease in their memory and capacity to think; like Alzheimer's infection. In any case, the psychological capacity or readiness of an individual with Lewy body dementia is bound to change starting with one second then onto the next, which isn't care for Alzheimer's sickness. They additionally frequently have visual pipedreams (seeing things that aren't there) and fancies (accepting some falsehood). By all accounts, individuals with Lewy body dementia frequently have issues with development that take after Parkinson's infection. This is on the grounds that similar designs of the cerebrum are influenced in Lewy body dementia and Parkinson's infection.
 
 
Scientific Session 6Neurodegenerative Diseases
Neurodegenerative sickness essentially influences the neurons in the human cerebrum. Neurons are the structure squares of the sensory system which incorporates the mind and spinal line. Neurons regularly don't replicate or supplant themselves, so when they become harmed or pass on they can't be supplanted by the body. Neurodegenerative sicknesses are serious and weakening conditions that bring about reformist degeneration and/or demise of nerve cells.  Dementias are liable for the best weight of neurodegenerative infections, with Alzheimer's addressing roughly 60-70% of dementia cases.
 
 
Scientific Session 7Mind Diseases
The mind is the control focus of the body. It controls contemplations, memory, discourse, and development. It manages the capacity of numerous organs. At the point when the cerebrum is solid, it works rapidly and naturally. Be that as it may, when issues happen, the outcomes can be destroying. Irritation in the mind can prompt issues like vision misfortune, shortcoming and loss of motion. Loss of synapses, which occurs on the off chance that you endure a stroke, can influence your capacity to think plainly. 
 
 
Scientific Session 8Parkinson Disease Dementia
Parkinson's sickness (PD) is an age-related degenerative problem of certain synapses. It essentially influences developments of the body, yet different issues, including dementia, may happen. It isn't viewed as an inherited infection, albeit a hereditary connection has been recognized in few families. Sadness, nervousness, character and conduct changes, rest unsettling influences, and sexual issues are normally connected with Parkinson's sickness. As a rule, Parkinson's infection doesn't influence an individual's capacity to think, reason, learn, or recall (psychological cycles).
 
 
Scientific Session 9Neuropharmacology
Neuropharmacology is the logical investigation of the impacts of medications on the sensory system. Its essential center is the activities of meds for mental and neurologic problems just as those of medications of misuse. Medications that follow up on the sensory system, including energizer, antianxiety, anticonvulsant, and antipsychotic specialists, are among the most generally endorsed drugs.
 
 
Scientific Session 10Neuro Oncology and CNS
Neuro-oncology is the investigation of mind and spinal line neoplasms, a considerable lot of which are extremely perilous and dangerous (astrocytoma, glioma, glioblastoma multiforme, ependymoma, pontine glioma, and cerebrum stem tumors are among the numerous instances of these). Among the harmful mind tumors, gliomas of the brainstem and pons, glioblastoma multiform, and high-grade (profoundly anaplastic) astrocytoma are among the most exceedingly awful.
 
 
Geriatrics or geriatric medication could also be a specialty that focuses on health care of older people. It aims to push health by preventing and treating diseases and disabilities in older adults. There is no set age at that patients also are underneath the care of a specialist or geriatric.
 
 
Scientific Session 12Clinical Trials and Drug Development
Thorough clinical preliminaries on Dementia drugs are proceeding in USA and UK under the direction of Alzheimer's general public and it is accounted for that there is less support of individuals. The majority of medications are in second and third stages. The greater part of clinical preliminaries are done in explicit territories are amyloid beta plaques, the resistant framework, tau tangles. New drugs for Dementia being created in 2014/2015, 31% were named side effects adjusting. There are numerous advancements are going on in Drug disclosure of Dementia as old medicines can't stop the movement of Dementia.
 
 
Molecular biological research has considerably deepened our understanding of the pathophysiological basis of Alzheimer's dementia. Considerable progress has been made in our understanding of the genetics and molecular biology of dementia. Some genetic risk factors have been identified so far, but only a small proportion of AD cases can be explained by specific gene mutations. Genes may be related to disease in two ways: through autosomal-dominant mutations, in themselves sufficient to cause the disease alternatively, gene variations (polymorphisms) may indirectly increase disease risk without being sufficient in them to cause the disorder.
 
 
Scientific Session 14Neuroimaging Biomarker
Alzheimer's disease Biomarkers, with emphasis on cerebrospinal fluid biomarkers of Neuroimaging-biomarkers allow an early diagnosis in preclinical stages of Alzheimer’s disease. Biomarker changes in patients with late-onset AD, including findings from studies using structural and functional magnetic resonance imaging (MRI), advanced MRI techniques (diffusion tensor imaging, magnetic resonance spectroscopy, perfusion), positron emission tomography with fluorodeoxyglucose, amyloid tracers, and other neurochemical tracers, and CSF protein levels.
 
 
 

 

 

Market Analysis

Market Analysis and Insights of Dementia Alzheimer Disease Market

Millions of people worldwide are affected by neurological disorders. More than six million people die because of stroke each year; over 80% of these deaths take place in low- and middle-income countries. More than 50 million people have epilepsy worldwide. It is estimated that there are globally forty eight million people with dementia with 7.7 million new cases every year - Alzheimer's disease is the most common cause of dementia and may contribute to 60–70% of cases. The prevalence of Anxiety is more than 10% worldwide.The global Neurological disorder market value $2.9 billion in 2016 is ready to achieve $14.8 Billon, rising at a Compound Annual rate of growth (CAGR) of eight percent, across the 7 Million by 2026 consistent with world information, a recognized leader in providing business info and analytics Alzheimer's disease is that the commonest style of dementia. The proportions of these with totally different varieties of Neurological Disorder are often dampened as follows:

Economically is predicated mostly on services and commerce of the 390,480 enterprises within the town, 80.6 % square measure engaged in commerce, transportation, and various services, 6.5 % in construction and 3.9 % in business. The bulk of Paris salaried workers fill 370,000 businesses services jobs, targeted within the north-western eighth sixteenth, seventeenth arrondissements.According to United Nations agency 47.5 million folks have Neurological disorders and each year 7.7 million new cases square measure showing. By 2030 total cases of Neurological Disorder is projected to be 75.6 million and virtually triple by 2050 to one hundred thirty-five million. Neurological Diseases percentage 60-70 you look after cases in Neuroscience & Dementia and second commonest condition of dementedness is tube-shaped structure Neurological Disorders that contributes Two Hundreds of cases everywhere the globe.

 

Past conferences report

Conference series LLC takes a great honor in announcing the commencement of 11th International Conference on Alzheimer’s disease and Dementia on May 24-25, 2018 at Vienna, AustriaEuro Dementia 2018 has received a benevolent response from all over the world.
 
The eminent personalities at the conference were Don Kulasiri, Lincoln University, New Zealand, V R Badrakalimuthu, Parklands Hospital, UK, Manabu Tamura, Ministry of Economy, Trade and Industry, Japan, Arturo Solís Herrera, Human Photosynthesis® Research Centre, Mexico, Li Zeng, National Neuroscience Institute, Singapore, Nedim Ongun, Burdur State Hospital, Turkey, Ying Wang, China Pharmaceutical University, China, Mario Durán-Prado, University of Castilla-La Mancha, Spain, Santosh Bangar, MIND Clinic for Senior Citizens, India
 
25th World Congress on Neurology & Neuroscience was organized during June 18-19, 2018 at Dublin, Ireland with the support and contribution of the Organizing Committee Members; we successfully hosted the event at the conference venue.
 
The eminent personalities at the conference were Hilary McDonagh , Sligo College of Further Education, Ireland was the moderator of Neuroscience Congress 2018. We are much thankful to Randall E. Merchant for his great support and help. The conference proceedings were carried out through various Scientific-sessions and plenary lectures, of which the following Speakers were highlighted as Keynote speakers Patricia A. Quigley, Nurse Consultant LLC, USA; Char-Nie Chen, Chinese University of Hong Kong, Hong Kong; Natallia HalinouskayaGomel State Medical University, Belarus;  Gabriele Saretzki, University of Newcastle upon Tyne, UK; Hebah Hefzy, Henry Ford Hospital, The Weizmann Institute of Science, Israel, Hilary McDonagh, Sligo College of Further Education, Ireland.
 
Conference Series takes a significant privilege in reporting the beginning of eleventh World Congress on Neurology March 15-17, 2018 London, UK. This has been led with the point and the unmitigated plan of advancing the improvements of new recognitions and thoughts for investigating the abnormal state of learning come to by academic network on Neuroscience..
The eminent personalities at the conference were  Harish C Pant, National Institutes of Health, USA, Evelyn M Garcia, Carilion Clinic, USA, Anthony E Kline, University of Pittsburgh, USA, David E Vance, and University of Alabama at Birmingham.

 

 

To Collaborate Scientific Professionals around the World

Conference Date November 21-22, 2022

For Sponsors & Exhibitors

[email protected]

Speaker Opportunity

Day 1

Supported By

Journal of Neurology and Neuroscience Journal of Neuropsychiatry Journal of Alzheimers Disease & Parkinsonism

All accepted abstracts will be published in respective Conference Series LLC LTD International Journals.

Abstracts will be provided with Digital Object Identifier by